4 products were found matching "1211441-98-3"!

No results were found for the filter!
Ribociclib
Ribociclib

Item number: TGM-T6199-500mg

Description: Ribociclib (LEE011) is an orally available, and highly specific CDK4/6 inhibitor (IC50:10/39 nM). Target: CDK, VEGFR. Smiles: C(N(C)C)(=O)C=1N(C=2C(C1)=CN=C(NC3=CC=C(C=N3)N4CCNCC4)N2)C5CCCC5. References: Li T, et al. Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231...
Keywords: LEE011
Application: Antineoplastic, Cyclin-dependent kinase (CDK) inhibitor
CAS 1211441-98-3
MW: 434.54 D
From 37.00€ *
Review
LEE011
LEE011

Item number: Cay17666-10

LEE011 is a cyclin-dependent kinase (CDK) inhibitor that targets cyclin D1/CDK4 and cyclin D3/CDK6 at nanomolar concentrations. It inhibits retinoblastoma protein phosphorylation, which prevents CDK-mediated G1-S phase transition, arresting the cell cycle in the G1 phase, suppressing DNA synthesis, and inhibiting...
Keywords: Ribociclib, 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide
Application: Cyclin D1/CDK4 & cyclin D3/CDK6 inhibitor
CAS 1211441-98-3
MW: 434.5 D
From 55.00€ *
Review
LEE-011
LEE-011

Item number: LKT-L1616.5

CDK4/6 inhibitor.
Keywords: LEE011, Ribociclib
Application: CDK4/6 inhibitor
CAS 1211441-98-3
MW: 434.54 D
From 72.00€ *
Review
LEE011
LEE011

Item number: SYN-1213-M001

Solid. Soluble in DMSO. Orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathways, with potential antineoplastic activity. Specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation...
Keywords: LEE-011, Ribociclib
Application: CDK4/CDK6 inhibitor
CAS 1211441-98-3
MW: 434,5 D
From 77.00€ *
Review